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GGF/Neuregulin Is a Neuronal Signal That Promotes
the Proliferation and Survival and Inhibits the
Differentiation of Oligodendrocyte Progenitors
Peter D. Canoll,1 J. M. Musacchio,1 Rebecca Hardy,5, 7 Transection of the optic nerve during development re-
sults in a severe reduction in the numbers of oligoden-Richard Reynolds,5 Mark A. Marchionni,6
drocytes, but not astrocytes, suggesting a dependenceand James L. Salzer2, 3, 4
of developing oligodendroglia on neuronal survival fac-1Department of Pharmacology
tors (David et al., 1984; Fulcrand and Privat, 1977), a2Department of Cell Biology
finding confirmed in coculture studies (Levine, 1989;3Department of Neurology
Shaw et al., 1996). Transection of the adult optic nerve4The Kaplan Cancer Center
results in a substantial reduction in the expression ofNew York University Medical School
myelin-related genes by oligodendrocytes (Kidd et al.,New York, New York 10016
1990; McPhilemy et al., 1990), indicating that later in5Department of Anatomy
development axons regulate oligodendrocyte differenti-Charing Cross and Westminster College
ation. Finally, neurons and neuronal extracts are knownLondon W68RF
to provide a mitogenic signal for both immature andUnited Kingdom
mature oligodendrocytes (Chen and DeVries, 1989; Ed-6Cambridge NeuroScience, Incorporated
gar and Pfeiffer, 1985; Wood and Bunge, 1986) that1 Kendall Square, Building 700
depends, in part, on the electrical activity of the axonCambridge, Massachusetts 02139
(Barres and Raff, 1993).
Characterization of the factors that regulate oligoden-
drocyte proliferation, differentiation, and survival has
Summary been facilitated by the ability to generate and analyze
cells at different stages of the oligodendrocyte lineage.
We show that GGF/neuregulin is a mitogen for pro- Cells at different stages of this lineage can be distin-
oligodendrocytes (O41/O12 cells), oligodendrocytes guished, in turn, by their morphology and by their ex-
(O41/O11 cells), and type-2 astrocytes. Heregulin b1, pression of different antigenic markers (Pfeiffer et al.,
another neuregulin isoform, is also mitogenic.The pro- 1993; Raff, 1989). An early cell in the lineage, the O-2A
liferative effect of glial growth factor (GGF) does not cell, is recognizable by its bipolar morphology, by its
require, but is greatly potentiated by, serum factors. expression of a ganglioside recognized by the A2B5
GGF also promotes the survival of pro-oligodendro- monoclonal antibody, and by its failure to express mark-
cytes under serum-free conditions. High levels of GGF ers of either mature astrocytes, such as glial fibrillary
reversibly inhibit the differentiation and lineage com- acidic protein (GFAP), or of oligodendrocytes, including
mitment of oligodendrocyte progenitors and, in differ- galactocerebroside (GalC). While the normal fate of
entiated cultures, result in loss of O1 and myelin basic these progenitor cells in vivo is probably to develop into
protein expression. All three erbB receptors are ex- oligodendrocytes (Monteros et al., 1993), some plastic-
pressed by progenitors and are activated by GGF; the ity exists that is dependent on unknown environmental
relative abundance of these receptors changes during signals (Levison and Goldman, 1993). In vitro, O-2A cells
differentiation. Finally, cortical neurons release a solu- demonstrate a great deal of phenotypic plasticity, differ-
ble mitogen for pro-oligodendrocytes that is specifi- entiating into either oligodendrocytes or type-2 astro-
cally blocked by antibodies to GGF. These results im- cytes depending on culture conditions (Raff, 1989).
plicate the neuregulins in the neuronal regulation of When cultured in the presence of low concentrations of
oligodendrocyte progenitor proliferation, survival, and serum, these cells progressively differentiate along the
differentiation. oligodendrocyte lineage, sequentially expressing glyco-
lipids recognized by the O4 antibody and the O1 anti-
body (which reacts with GalC) and then myelin-specificIntroduction
proteins, including myelin basic protein (MBP) (Pfeiffer
et al., 1993). In contrast, culturing cells in the presenceOligodendrocyte progenitors arise from the subventric-
of high concentrations of serum, or in the presence ofular zone (SVZ) and migrate out from there into devel-
certain growth factors such as ciliary neurotrophic fac-oping white matter, differentiating and proliferating en
tor, favors the expression of astrocytic markers, notablyroute (Altman, 1966; Goldman, 1992). From the time
GFAP (reviewed by Raff, 1989). Thus, cultures greatlythese cells migrate out from the SVZ and come to reside
enriched in O-2A cells (A2B51/O42), pro-oligodendro-in white matter tracts where they myelinate axons, they
cytes (O41/O12), oligodendrocytes (O41/O11), orare almost continually in a neuronal environment. In-
type-2 astrocytes (GFAP1) may be generated by varyingdeed, a variety of studies indicate that neurons pro-
the conditions of cell culture.foundly influencethe survival, proliferation, and differen-
By using such culture models, several candidate mito-tiation of cells of the oligodendrocyte lineage (reviewed
gens and survival factors have been identified that areby Barres and Raff, 1994; Hardy and Reynolds, 1993a).
effective at different stages of the oligodendrocyte lin-
eage. Among the best-characterized are platelet-
derived growth factor (PDGF), which is mitogenic for7 Present address: Brookdale Center for Molecular Biology, The
early cells in the oligodendrocyte lineage (i.e., A2B51/Mount Sinai Medical Center, One Gustave Levy Place, New York,
New York 10029. O42) (Noble et al., 1988; Richardson et al., 1988), and
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basic FGF (bFGF), which is a mitogen for more differenti- Results
ated oligodendrocytes (Eccleston and Silberberg, 1984;
GGF Is a Potent Mitogen with Pleiotropic EffectsFressinaud et al., 1995; Saneto and Vellis, 1985). When
on Cells of the Oligodendrocyte Lineageused in combination, these two growth factors cooper-
To investigate the potential effects of GGF on cells of theate to inhibit the differentiation and maintain the prolifer-
oligodendrocyte lineage, we first established cultures ofation of oligodendrocyte progenitors (Bo¨gler et al., 1990;
oligodendrocyte progenitors from neonatal rat cortexCollarini et al., 1992; McKinnon et al., 1990). PDGF and,
essentially as described (Louis et al., 1992). Cells werepossibly, bFGF also promote the survival of oligoden-
expanded by supplementing the media with B104 condi-drocyte progenitors (Barres et al., 1992; Yasuda et al.,
tioned media. Cells in the supplemented media had a1995). Other factors that promote proliferation or sur-
bipolar morphology and remained highly proliferative,vival (or both) of oligodendrocyte progenitors include
and >95% of the cells expressed vimentin and A2B5,neurotrophin-3 (Barres et al., 1993) and insulin-like
but not O4, O1, or GFAP. When switched to a definedgrowth factor (McMorris and Dubois-Dalcq, 1988; for a
media to which 0.5% serum was added to enhancereview, see Barres and Raff, 1994). All of these factors
survival (DM1), the cells rapidly acquired a multipolarare released by astrocytes; bFGF and PDGF are ex-
morphology and began to express the O4 antigen. Afterpressed and released by neurons as well (Dutly and
several days, the cells developed a complex network ofSchwab, 1991; Hardy and Reynolds, 1993a; Pettman et
processes and began to express the O1 antigen. By 3al., 1986; Yeh et al., 1991).
days in DM1, essentially all cells were O41 and over 50%Neurons and a neuronal cell line also release a mito-
were O11 and MBP1. Cell differentiation coincided withgen(s) that is distinct from either PDGF or bFGF (Gard
a substantial reduction in the proliferative rate. The la-and Pfeiffer, 1990; Hardy and Reynolds, 1993b; Hunter
beling index of cells grown in B104 conditioned mediaand Bottenstein, 1991; Levine, 1989). We considered
was greater than 50% after a 4 hr pulse of bromodeoxy-whether the neuregulins might correspond to this un-
uridine (BrDU) but decreased to less than 5% when cellsidentified mitogenic activity. The neuregulins are a family
were grown in DM1 for 3 days.of soluble and transmembrane protein isoforms en-
To characterize the effects of GGF, cells grown in DM1
coded by a single gene that includes the glial growth
for 3 days were treated with 200 ng/ml GGF for 16 hr,
factors (GGFs), the neu differentiation factor (NDF), the
the last 4 hr in the presence of BrDU. Cells were then
heregulins, and the acetylcholine receptor–inducing ac-
fixed and stained for O4, O1, and BrDU. The results,
tivity (ARIA) (Marchionni et al., 1993; Peles and Yarden, shown in Figure 1, demonstrate that GGF had a number
1993). These proteins mediate their effects by binding of dramatic effects. After GGF treatment, all cells re-
to and signaling via a family of receptor tyrosine kinases mained O41 (Figure 1B), but most treated cells had a
comprised of erbB2, erbB3, and erbB4 (reviewed by less complex morphology than control cells (Figure 1A),
Carraway and Burden, 1995). Although initially purified with fewer and flatter processes suggestive of a less
as a potential ligand for erbB2, recent studies suggest mature phenotype. Consistent with this change in mor-
that neuregulins bind to erbB3 and erbB4, which hetero- phology, significantly fewer O11 cellswere present after
dimerize in various combinations with each other, and GGF treatment compared with controls (Figures 1C and
with erbB2 and the epidermal growth factor receptor to 1D). Finally, there was a substantial increase in the num-
effect subsequent signaling. ber of BrDU-positive nuclei in the treated compared with
We now report that a soluble recombinant form of the control cells (Figures 1E and 1F). We have quanti-
human neuregulin, corresponding to glial growth factor tated these effects over a range of GGF concentrations.
2 (GGF2), is a potent mitogen for oligodendrocytes and The labeling index was determined separately for O41
their progenitors. GGF also blocks their differentiation and O11 cells. In each case, the labeling index in-
at the O41 stage and enhances the survival of these creased with higher concentrations of GGF (Figure 1G).
cells. In addition, we demonstrate that the mitogenic This was paralleled by the loss in O1 expression (Figure
effect of cortical neuron–conditioned media (CCM) on 1H). We consider first the mitogenic response to the
oligodendrocyte progenitors is inhibited by antibodies neuregulins.
to GGF. Finally, neuregulin receptors are shown to be GGF is a potent mitogen for O41 cells. The labeling
expressed in cells at various stages of the lineage and index of the O41 cells increased significantly with con-
can be activated by exposure to GGF. These results centrations of GGF as low as 0.2 ng/ml and reached a
indicate that the neuregulins are physiologic mitogens plateau of z40% at concentrations of 200 ng/ml or
for oligodendrocyte progenitors and have potent effects greater (Figure 1G); a half maximal response was ob-
served with concentrations of GGF of about 20 ng/mlon their survival and differentiation.
(Figure 1 legend continued)
cells in the field. O4 and O1 staining was visualized with a rhodamine-conjugated antibody, BrDU with a fluorescein-conjugated antibody.
Separate fields from a single experiment are shown that are representative of the staining pattern of each antibody. Scale bar, 50 mm (A–D);
100 mm (E and F).
(G) O41 progenitors and O11 oligodendrocytes exhibit different mitogenic responses to GGF. The labeling index was determined for O41
and O11 cells after adding different concentrations of GGF for 16 hr; BrDU was added for the last 4 hr. Each point represents the mean 6
SEM from two independent experiments.
(H) Loss of O1 expression with increasing concentrations of GGF. The percentage of O11 cells was determined from cultures that were
treated with increasing concentrations of GGF (described above in [G]). Each point represents the mean 6 SEM from two independent
experiments.
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Figure 1. Pleiotropic Effects of GGF on Cells in the Oligodendrocyte Lineage
(A)–(F) Effects of GGF on cells of the oligodendrocyte lineage. Cells were allowed to differentiate in DM1 for 3 days; cultures were then fed
with DM1 without (A, C, and E) or with 200 ng/ml GGF (B, D, and F) for 16 hr. In each case, BrDU was added during the last 4 hr. Cultures
were fixed and stained for O4 (A and B), for O1 (C and D), or for BrDU (E and F). (A)–(D) were counterstained with Hoechst dye to identify all
(Figure 1 legend continued on previous page)
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Figure 2. GGF Is Mitogenic for MBP1 Oligo-
dendrocytes
Cells maintained in DM1 for 3 days were
treated with 200 ng/ml GGF for 16 hr; BrDU
was added during the last 4 hr of GGF treat-
ment. Cells were immediatedly fixed and
stained for MBP and BrDU and counter-
stained with Hoechst dye to identify all cells
in the field. (A) shows the Hoechst-stained
cells, including an MBP1 oligodendrocyte;
(B) demonstrates multiple BrDU1 nuclei in
the same field. The nucleus of the oligoden-
drocyte is BrDU1 and is indicated by an
arrow in each panel. Scale bar, 25 mm.
(z0.5 nM). The mitogenic effect is not specific for the observed that 3 days later, over 50% of the cells ex-
pressed high levels of GFAP and developed a stellateGGF isoform, as heregulin b1, another neuregulin iso-
form expressed in theCNS, also has proliferative effects. morphology characteristic of type-2 astrocytes (Figure
3A). In parallel, the labeling index rapidly declined toO41 cells treated for 16 hr with conditioned media, with
or without heregulin b1 (Jo et al., 1995), displayed a 2.5% 6 0.7% (Figure 3C). After treatment with GGF for
16 hr, there was a striking change in the morphology ofcomparably robust mitogenic response. Thus, cultures
treated with control media had a labeling index of the astrocytes with some cells exhibiting a few highly
extended GFAP1 processes (Figure 3B). Of particular3.4% 6 0.4%, whereas heregulin b1–treated cultures
had a labeling index of 33.3% 6 2.4%. note, the labeling index of the total population of cells
increased markedly to 14.5% 6 1.2% (Figure 3D). MostGGF is also mitogenic for O11 cells, although they
appear to be less responsive than the total population of the BrDU1 cells were GFAP2. In separate experi-
ments, type-2 astrocytes, identified by double labelingof O41 cells. The labeling index of O11 cells in the
control cultures was 0%; it increased to nearly 5% with with GFAP, also demonstrated a modest but significant
mitogenic response, with the labeling index increasingconcentrations of GGF up to 20 ng/ml and increased to
just above 15% at higher concentrations of GGF (200– from 0% in the controls to 8% in the GGF-treated cul-
tures.2000 ng/ml). In separate experiments, a similar mito-
genic effect on MBP1 cells was also observed, i.e.,
there were no MBP1/BrDU1 cells in controls versus GGF Has Direct Mitogenic Effects
We next examined whether the mitogenic activity of16.7% 6 4.3% in the cultures treated with 200 ng/ml
GGF. A representative example of an MBP1 cell that GGF was direct or whether GGF stimulated proliferation
by inducing progenitor cells to release another growthincorporated BrDU is shown in Figure 2. However, be-
cause GGF treatment may down-regulate the expres- factor that in turn increased proliferation. To this end,
we first determined the neutralizing activity of an anti-sion of these mature markers as described below, these
studies may underestimate the actual mitogenic re- body toGGF. PreincubatingGGF with this antibody prior
to adding it to O41 cells completely inhibited its mito-sponse of oligodendrocytes.
Indeed, one of the most striking effects of short-term genic effect (Figure 4A); thesame antibody did not inhibit
the mitogenic effect of bFGF or PDGF, thereby demon-treatment with GGF was a marked decrease in the num-
ber, and percentage, of O11 cells from these more dif- strating its specificity (data not shown). We next col-
lected media conditioned by O41 cells grown for 1 dayferentiated cultures. This decrease was dose dependent
and inversely correlated with the mitogenic response to with GGF (200 ng/ml) and added this media to cells
directly or after preincubation with the GGF neutralizingGGF (see Figures 1G and 1H). Treatment with 200 ng/
ml GGF resulted in a dramatic reduction in the absolute antibody. Conditioned media from GGF-treated cells,
when added directly, resulted in a 6-fold increase in thenumber of 041/011 cells from 26.5 6 4.8 per high power
field (HPF) in control cultures to 4.5 6 0.7 per HPF; thus, labeling index of the recipient O41 cells after 16 hr
(Figure 4B). The mitogenic effect of this conditionedthe percentage decrease in 041/011 cells is not due
to a selective expansion of 041/012 cells by GGF. In media was completely inhibited by preincubation with
the anti-GGF antibody. Incubation with an anti-PDGFseparate experiments, a similar decrease in the absolute
number of MBP1 cells was observed in GGF and here- antibody, which was used as an antibody control, had
no effect on the mitogenic activity of the conditionedgulin b1–treated cultures. These findings suggest that
the loss of O1 and MBP expression reflects reversion media. These results demonstrate that the mitogenic
effect of GGF on O41 cells is direct and does not resultof O11 cells to the O12 stage or selective cytotoxicity
of neuregulins for O11 cells (for example, see Muir and from the release of other mitogens into the conditioned
media.Compston, 1996). As total cell numbers increase during
the period of GGF treatment and cells appear viable, To determine whether the mitogenic activity of GGF
was dependent on serum factors, oligodendrocyte pro-we favor the former possibility. Further studies are un-
derway to elucidate the precise mechanism involved. genitors were switched from media supplemented with
B104 conditioned media to a defined media without anyFinally, to determine whether GGF was mitogenic for
type-2 astrocytes, O-2A cells growing in media supple- serum added. After 3 days, GGF was added to these
cultures and the extent of proliferation was measuredmented with B104 conditioned media were switched to
media containing 20% fetal bovine serum (FBS). We as above. In the absence of serum and GGF, the rate
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Figure 3. GGF Effects on Type-2 Astrocytes
Type-2 astrocyte–enriched cultures were es-
tablished by growing cells for 3 days in media
containing 20% FBS. Media was then added
without (A and C) or with 200 ng/ml GGF (B
and D) for 16 hr, the last 4 hr with BrDU. Cells
were fixed and stained for GFAP expression
(fluorescein secondary) and counterstained
with a nuclear dye (A and B) or stained for
BrDU (fluorescein antibody) as shown in (C)
and (D). Separate fields from a single experi-
ment are shown that are representative of the
staining pattern of each antibody. Scale bar,
25 mm.
of proliferation was markedly reduced, with a labeling or low concentrations of serum (for example, see Barres
et al., 1992). Consistent with earlier reports, we notedindex of 0.4% 6 0.2% after a 4 hr incubation with BrDU.
In contrast, in cultures treated with 200 ng/ml GGF, the in the studies described above large numbers of dead
cells in the control cultures following serum withdrawal.rate of proliferation was significantly increased, with a
labeling index of 7.1% 6 0.3%. These results indicate By contrast, GGF-treated cultures had notably fewer
dead cells, strongly suggesting that GGF promotes thethat the mitogenic effect of GGF on oligodendrocyte
progenitors does not require serum, although it is greatly survival of oligodendrocyte progenitors. To directly ex-
amine whether GGFhas survival effects for oligodendro-enhanced in the presence of low concentrations of
serum. cyte progenitors, cells were grown in DM1 for 3 days
then switched to a serum-free defined media with or
without GGF. Survival was analyzed after an additionalGGF Promotes Oligodendrocyte
Progenitor Survival 12 or 24 hr. Initial experiments were done in N2 media
and demonstrated that GGF strongly promoted oligo-Survival of oligodendrocyte progenitors in vitro is de-
pendent on the presence of a number of growth factors dendrocyte progenitor survival as assessed by nuclear
dye exclusion (data not shown). However, because the
N2 media contains concentrations of insulin (5 mg/ml)
that enhance oligodendrocyte survival (Barres et al.,
1992), these experiments were repeated in Dulbecco’s
modified Eagle’s medium (DMEM) without any supple-
ments. Similar effects on survival were apparent under
these more stringent conditions (Figure 5). Thus, in the
absence of GGF, z50% of the cells were dead at 12 hr
(Figure 5A), whereas at 200 ng/ml GGF only about 10%
of the cells were dead. After 24 hr in DMEM, most of
the cells were dead in the control cultures, whereas
substantial numbers of viable cells remained in the
treated cultures (data not shown). Consistent with this
assay, the control wells had many more pyknotic cells
in small aggregates than the GGF-treated wells; signifi-
Figure 4. GGF Is a Direct Mitogen for O41 Cells
cantly fewer cells in the control cultures also remained
Left: the mitogenic effect of GGF on O41 cells is blocked by a attached after changing the media. The survival effects
neutralizing antibody. O41 cells (3 days in DM1) were grown for 16
of GGF on O41 cells were dose dependent with a halfhr in DM1 without GGF (control), with GGF, with GGF and an anti-
maximal response of z2 ng/ml (Figure 5C).PDGF antibody, or with GGF and an anti-GGF antibody; BrDU was
added during the last 4 hr. Cells were fixed and the percentage of Because of greatly improved cell survival in the pres-
labeled nuclei was determined for each condition. Bars represent ence of serum, all subsequent studies described below
the mean 6 SEM of duplicate wells from two independent experi- have been done in the presence of 0.5% serum, i.e.,
ments. in DM1.
Right: GGF is a direct mitogen. O41 cells (3 days in DM1) were
incubated for 16 hr with conditioned media from control cells or
from cells treated with GGF (GGF conditioned media). The GGF GGF Maintains Progenitor Cell Proliferation
conditioned media was added directly to recipient cells or added and Inhibits Differentiation
with anti-GGF or anti-PDGF neutralizing antibodies. A 4 hr pulse of
To determine whether the effects of GGF are sustainedBrDU was given and the labeling index determined. Bars represent
or, like PDGF are limited to a few cell cycles (Raff et al.,the mean 6 SEM of duplicate wells from two independent experi-
ments. 1988), we treated O-2A cells with GGF chronically. We
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Figure 5. GGF Promotes the Survival of Oligodendrocyte Progenitors
(A) and (B) GGF maintains cell survival after serum withdrawal. Cells were switched from media containing 0.5% serum to DMEM without any
serum for 12 hr without (A) or with (B) 200 ng/ml GGF. Dead cells are stained with a red nuclear stain; all other nuclei are stained blue.
Representative fields are shown. Scale bar, 100 mm.
(C) Dose response of survival effects. The percentages of dead cells after switching cells to DMEM without any serum for 12 hr in the presence
of increasing concentrations of GGF are shown. Each bar represents the mean 6 SEM from three experiments done in duplicate.
found that the mitogenic effects of GGF are sustained; were O11 or had acquired the complex morphology
characteristic of mature oligodendrocytes (Figures 6Cafter 3 days of GGF treatment (200 ng/ml), the labeling
index was greater than 30% (Table 1) and remained and 6D). This inhibition of differentiation reversed follow-
ing withdrawal of GGF; we observed that 3 days aftercomparably elevated for several weeks provided that
cells continued to be passaged in the presence of GGF GGF withdrawal, over 50% of the cells became 011.
Thus, treatment with high doses of GGF reversibly(data not shown). Cells treated for 3 days with GGF were
also analyzed for their expression of oligodendrocyte blocks oligodendrocyte differentiation at the O41/O12
stage.markers. Such cells progressed to the O41/O12 stage
but were inhibited from differentiating to the O41/O11 GGF similarly inhibits differentiation of O-2A cells into
type-2 astrocytes (Table 2). Cells were switched to me-stage (Table 1). For example, after 3 days of GGF, essen-
tially all cells were O41 and had a multipolar morphology dia containing 20% FBS with or without 200 ng/ml GGF
for 3 days. When grown in 20% FBS with GGF, fewer(Figures 6A and 6B), but less than 10% of the cells
Table 2. GGF Maintains the Proliferation and Inhibits theTable 1. GGF Maintains the Proliferation and Inhibits the
Differentiation of O-2A Cells Grown in DM1 Differentiation of O-2A Cells Grown in 20% FBS
Growth Condition %041 %011 %BrDU1 Growth Condition %GFAP1 %BrDU1
2GGF 100 51.9 6 2.5 5.7 6 1.2 2GGF 48.4 6 4.2 5.5 6 1.4
1GGF 4.7 6 2.3 19.7 6 2.51GGF 100 8.1 6 0.6 31.8 6 1.3
O-2A cells in B104 conditioned media were switched to media con-O-2A cells in B104 conditioned media were switched to DM1 with
or without 200 ng/ml GGF for 3 days. Cultures were pulsed with taining 20% FBS with or without 200 ng/ml GGF for 3 days. Cultures
were pulsed with BrDU for 4 hr and fixed and stained for GFAP andBrDU for 4 hr and fixed and stained for O4, for O1, and for BrDU.
Data shown represents the mean 6 SEM of duplicate wells from for BrDU. Data shown represents the mean 6 SEM of duplicate
wells from three independent experiments.three independent experiments.
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Figure 6. GGF Inhibits the Differentiation
of O-2A Cells into Oligodendrocytes or
Astrocytes
Cells were grown in DM1 (A–D) or in 20% FBS
(E and F) without (A, C, and E) or with (B, D,
and F) GGF for 3 days. Cultures were fixed
and stained for O4 (A and B), for O1 (C and
D), or for GFAP (E and F). O4 and O1 staining
was visualized with a rhodamine-conjugated
antibody, GFAP with a fluorescein-conju-
gated antibody; in each case, nuclei were
counterstained (blue). Scale bar, 100 mm
(A–D); 25 mm (E and F).
cellsexpressed detectable levels of GFAP than controls. than 25% of the cells were induced to differentiate into
O11 oligodendrocytes (Table 2). Taken together withCells that did express GFAP had a unique morphology,
characterized by a few highly extended, GFAP1 pro- the studies described above, these results indicate that
GGF inhibits the differentiation of O-2A cells and main-cesses (Figures 6E and 6F). Cells grown in 20% FBS
with GGF also continued to proliferate at high levels, tains them as proliferative bipotential cells.
indicated by a labeling index of 19.7% 6 2.5% after a
4 hr BrDU pulse compared with 5.5% 6 1.4% in control Cortical Neurons Release Neuregulins
Previous studies demonstrated that cortical neurons re-cultures.
lease mitogenic factors for O-2A progenitor cells that
are distinct from bFGF or PDGF (Hardy and Reynolds,GGF Maintains O-2A Cells as Bipotential Cells
The ability of GGF to maintain cells as proliferating O41/ 1993b). We have extended these studies by examining
the effects of the CCM on O-2A cells that were allowedO12 progenitors suggested it might inhibit them from
committing to either the oligodendrocyte or astrocyte to differentiate in DM1. O-2A cells were grown for 12 hr
or 3 days in DM1 and were then treated with 33% CCMlineages. To test this hypothesis, we grew the O-2A cells
in DM1 with or without GGF (200 ng/ml) for 3 days, for 16 hr; BrDU was added for the last 4 hr. Analysis of
BrDU incorporation showed that the CCM was mito-switched all cells to media supplemented with 20% FBS
without GGF for an additional 3 days, and then stained genic for cells in both conditions, inducing a 2–3-fold
increase in cell proliferation in each case (see Figure 7).for GFAP expression. Cells grown in DM1 without GGF
had largely become committed to the oligodendrocyte
lineage;despite switching to high serum conditions, less
Table 3. GGF Maintains O-2A Cells in an Uncommitted Stagethan 1% of cells expressed GFAP (Table 3). In contrast,
when cells were grown in DM1 with GGF for 3 days and DM1 → FBS FBS → DM1
then switched to 20% FBS without GGF, greater than
Growth Condition %GFAP1 %01110% of the cells were induced to express GFAP. Thus,
2GGF 0.4 6 0.1 5.9 6 0.2GGF maintained a significant number of the cells in an
1GGF 11.5 6 1.1 27.0 6 2.4uncommitted bipotential state, allowing them to differ-
entiate into astrocytes in media containing 20% FBS. Left column: Cells were grown in DM1 with or without GGF (200 ng/
ml) for 3 days and then switched to 20% FBS for 3 days withoutA similar experiment demonstrated that GGF also in-
GGF. Cultures were then stained for GFAP.hibits commitment to the astrocyte lineage. Cells were
grown in 20% FBS for 3 days with or without GGF, and Right column: Cells were grown in 20% FBS with or without GGF
(200 ng/ml) for 3 days and then switched to DM1 for 3 days withoutwerethen switched toDM1 without GGFfor an additional
GGF. Cultures were then stained for O1. Data shown represents the3 days. Only about 5% of the cells grown initially without
mean 6 SEM of duplicate wells from three independent experi-GGF expressed O1. In contrast, when cells were grown
ments.
in 20% FBS with GGF and then switched to DM1, more
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a maximal mitogenic response based on comparative
dose response curves (data not shown). As shown in
Figure 7A, cells switched to DM1 for 12 hr (which con-
sisted of recently differentiated O41/O12 cells) dis-
played a robust response to all three growth factors. In
contrast, more mature cells that had been maintained
in DM1 for 3 days had significantly different mitogenic
response to these growth factors. In particular, the mito-
genic effect of PDGF was markedly diminished on these
more differentiated cells, whereas that of bFGF was
increased in general agreement with previous reports
(for example, see Gard and Pfeiffer, 1993). The mitogenic
effect of GGF was similar for cells in both cases, indicat-
ing that it has a pattern of mitogenic activity distinct
from either bFGF or PDGF.
To identify which, if any, of these polypeptide growth
factors were released by cerebral neurons, we incu-
bated the CCM with various neutralizing antibodies for
30 min prior to adding it to cells maintained in DM1 for
either 12 hr or 3 days. Results are shown in Figure 7B. In
both cases, the anti-GGF antibody significantly inhibited
the CCM-induced proliferation. The inhibition of prolifer-
ation was more pronounced with the mature O41 cul-
tures (3 days in DM1) as compared with the newly differ-
entiated O41 cells, i.e, a 68% inhibition of the CCM
effect compared with a 48% inhibition, respectively. We
also observed a significant inhibition of proliferation with
the anti-PDGF antibodies, particularly in the case of
the newly differentiated O41 cells (12 hr in DM1). By
contrast, there were no significant effects of the anti-
bFGF antibodies on the mitogenic activity of the CCM
when it was tested on cells grown for 3 days in DM1.Figure 7. GGF Is a Mitogen Released by Cerebral Cortical Neurons
in Primary Culture Taken together, these studies indicated that cortical
neurons release both PDGF and GGF (or a related neu-(A) PDGF, bFGF, and GGF have distinct mitogenic effects on oligo-
dendrocyte progenitors at different stages of differentiation. Oligo- regulin isoform), with PDGF accounting for much of the
dendrocyte progenitors were grown in DM1 for 12 hr or 3 days and mitogenic activity for early lineage cells and GGF for
then treated with PDGF (10 ng/ml), bFGF (10 ng/ml), or GGF (200 cells at later stages of differentiation.
ng/ml) for 16 hr. Analysis of BrDU incorporation (4 hr pulse) showed
that the mitogenic response to the three growth factors changes
as the cells become more differentiated. Bars represent the mean 6
Regulated Expression of Neuregulin ReceptorsSEM of duplicate wells from two to three independent experiments.
(B) GGF and PDGF are released by cortical neurons. Cells were by Cells in the Oligodendrocyte Lineage
grown in DM1 for 3 days and then treated for 16 hr with 33% CCM Neuregulins bind to and signal via a subfamily of recep-
that had been preincubated with an anti-GGF, an anti-PDGF, or tor tyrosine kinases that include erbB2, erbB3, and
an anti-bFGF antibody. BrDU was added during the last 4 hr of erbB4. To determine which of these receptors were ex-
incubation. The data has been normalized to the effect of the CCM
pressed by cells in the oligodendrocyte lineage, we pre-in both cases. Bars represent the mean 6 SEM of duplicate wells
pared lysates from O-2A cells grown in B104 condi-from three independent experiments.
tioned media, from type-2 astrocyte–enriched cultures
grown in 20% FBS, and from cells that increasingly dif-
ferentiated into O41/O11 oligodendrocytes grown inImmunofluorescence analysis revealed that essentially
all of the cells had advanced to the O41 stage at both DM1 for 1, 2, 3, or 4 days. Lysates were fractionated by
SDS–polyacrylamide gel electrophoresis (SDS–PAGE)time points; therefore, the CCM was mitogenic for O41
cellsunder the conditions tested. Double staining further and immunoblotted with a panel of receptor-specific
antibodies. As controls, we analyzed lysates prepareddemonstrated that all of the BrDU-positive cells were
O41/O12 (data not shown). The CCM-treated cells had from rat Schwann cells and from newborn rat cerebrum.
Results, shown in Figure 8A, demonstrate that, with thea distinctive multipolar morphology with four to ten wide
flat processes consistent with our previous report exception of Schwann cells, which are knownto express
only erbB2 and erbB3 proteins (Levi et al., 1995), all(Hardy and Reynolds, 1993b) and similar to the effects
we observed with GGF treatment (see Figure 1). three receptors were expressed in each cell type and
in the brain. Of note, erbB3 is a prominent neuregulinWe next compared the mitogenic response of the
oligodendrocyte progenitors grown in DM1 for 12 hr or receptor protein in Schwann cells and in cells of the
oligodendrocyte lineage. In contrast, erbB4 appears tofor 3 days with a series of growth factors including bFGF
(10 ng/ml), PDGF (10 ng/ml), and GGF (200 ng/ml). The predominate in the neonatal brain, which may reflect its
high level expression by neurons in several regions ofdoses of growth factors used were chosen to provide
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the developing forebrain (characterized as tyro 2 in Lai
and Lemke, 1991). Of particular interest, as cells pro-
gress along the oligodendrocyte lineage, there is a de-
crease in erbB4 and an increase in erbB2 expression;
in some experiments, this transition was even more pro-
nounced than is shown here. Because these cultures,
even those maintained in DM1 for 4 days, contain a
mixture of O12 and O11 cells, the expression of erbB4
may be even further reduced in the O11 cells. Additional
studies to address this point are in progress.
We next analyzed which proteins were phosphory-
lated following GGF treatment. GGF was briefly added to
cultures of Schwann cells, to O-2As (in B104 conditioned
media), to O41 cells (3 days in DM1), and to type-2
astrocyte–enriched cultures (3 days in 20% FBS). Ly-
sates were prepared, fractionated by SDS–PAGE, blot-
ted, and probed with an anti-phosphotyrosine antibody.
In each case, GGF treatment resulted in increased phos-
phorylation of a protein band of z185 kDa, with the O41
cells demonstrating the most robust response (Figure
8B). In some experiments, a protein of similar size is
constitutively phosphorylated at lower levels in the O-2A
and O41 cells. To determine which of theerbB receptors
were phosphorylated following GGF treatment, tyrosine
phosphorylated proteins were immunoprecipitated and
analyzed by immunoblotting with antibodies specific for
each of the receptor proteins (Figure 8C). As a control,
total lysate from the O-2A cells was also analyzed. In
each case, phosphorylated erbB3 is quite prominent.
Phosphorylated forms of erbB2 and erbB4 were only
readily detected in the case of the O41 cells but were
also present in the case of the type-2 astrocytes with
higher sample loading (data not shown).
Discussion
GGF has long been known to be a potent mitogen for
Schwann cells and astrocytes (Brockes et al., 1980) but
had not been recognized previously to be a mitogen for
oligodendrocytes. We have demonstrated in this report
that GGF is also a potent mitogen and survival factor
for cells of the oligodendrocyte lineage and inhibits the
differentiation of pro-oligodendrocytes. These findings,
and their implications for the neuronal regulation of oli-
godendrocyte development, are considered below.
GGF Is Released by Neurons and Is Mitogenic
for Cells at Different Stages of the
Oligodendrocyte Lineage
We have found that GGF has potent mitogenic effects
Figure 8. Expression of Receptor Isoforms by Cells in the Oligoden-
for pro-oligodendrocytes and oligodendrocytes anddrocyte Lineage
modest mitogenic effects for type-2 astrocytes. The(A) Expression of erbB receptors by cells in the oligodendrocyte
O41 pro-oligodendrocyte exhibits the most robust mito-lineage. Detergent lysates were prepared from rat Schwann cells,
genic response to GGF, which correlates well with thefrom P0 cerebrum, and from O-2A cells in B104 conditioned media,
or grown in DM1 for 1–4 days or 20% FBS for 3 days. Samples were
fractionated by SDS–PAGE, blotted, and probed with antibodies
specific for erbB2, erbB3, and erbB4. (C) GGF induces phosphorylation of erbB receptors. O-2A cells in
(B) GGF induces phosphorylation of p185. Schwann cells, O-2A cells B104 conditioned media, O41 cells grown in DM1 for 3 days, and
growing in B104 conditioned media, O41 cells grown in DM1 for 3 type-2 astrocyte–enriched cultures grown in 20% FBS for 3 days
days, and type-2 astrocyte–enriched cultures growing in 20% FBS were treated with GGF for 2.5 min and tyrosine phosphorylated
for 3 days were lyseddirectly in detergent (2 lanes) or after treatment proteins were immunoprecipitated, separated by SDS–PAGE, blot-
with GGF for 2.5 min (1lanes). Detergent lysates (15 mg/lane) were ted, and probed with erbB receptor–specific antibodies. A detergent
subjected to SDS–PAGE, transferred onto nitrocellulose, and immu- lysate from untreated O-2A cells was run in the first lane as a control
noblotted with an anti-phosphotyrosine antibody. for antibody reactivity.
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extent of receptor phosphorylation. This mitogenic ac- 1989) and the neuroblastoma line B104 (Hunter and Bot-
tenstein, 1991) also release a soluble mitogen(s) for oli-tivity operates directly and does not require serum co-
factors, although it is significantly potentiated by low godendroglia that is distinct from PDGF and bFGF. We
have found that neurons cultured from embryonic cere-concentrations of serum. We have not examined the
mitogenic effect of GGF on undifferentiated O-2A cells, bral cortex release GGF into the culture media and that
this GGF is mitogenic for pro-oligodendrocytes. Withbecause, in the culture model we have used, these cells
exhibit high basal levels of proliferation as a result of this report, GGF, heregulin b1, and potentially other neu-
regulin isoforms expressed in the CNS (Ho et al., 1995)expansion in the neuroblastoma conditioned media.
However, addition of GGF results in the rapid tyrosine must now be considered likely neuronal mitogens for
oligodendroglia. (In preliminary studies, we have alsophosphorylation of a protein band of z185 kDa for O-2A
cells, suggesting that GGF may also be mitogenic for detected secretion of GGF by the B104 neuroblastoma
line.) In agreement with this possibility, cortical neurons,these cells. This has been confirmed in preliminary stud-
ies in which 5 ng/ml GGF resulted in a several fold in- which would be expected to regulate the development of
forebrain-derived oligodendrocyte progenitors, expresscrease in the proliferation of freshly panned GD31/O42
cells (R. R., unpublished data). high levels of GGF during development (Chen et al.,
1994). GGF and other neuregulins may also functionPrevious studies have shown that regulation of oligo-
dendrocyte proliferation is under the control of several as an axolemma-associated mitogen, as they do for
Schwann cells (Rosenbaum et al., 1996; J. L. S., unpub-mitogens that operate at different stages of the oligode-
ndrocyte lineage. Thus, PDGF acts on early progenitors, lished data). Of interest in this regard, Nordlund et al.
described the partial purification of a protein of 50 kDawhereas during the O41 pro-oligodendrocyte stage,
cells lose their responsiveness to PDGF and become from brain membrane preparations that is mitogenic for
both Schwann cells and oligodendrocytes (Nordlund etincreasingly responsive to bFGF (Gard and Pfeiffer,
1990). The transition from O41/O12 progenitors to O11 al., 1992) and have recently obtained evidence that it
may correspond to GGF(Rosenbaum et al., 1996). Takenoligodendrocytes coincides with a decrease in the mito-
genic response to bFGF (Gard and Pfeiffer, 1993). Our together, these results suggest that both soluble and
membrane-associated forms of the neuregulins areresults are consistent with these reports, as cells at an
early stage of differentiation (12 hr in DM1) responded likely to play an important role in regulating oligodendro-
cyte progenitor proliferation during development.equally to PDGF and bFGF whereas cells at later stages
of differentiation (3 days in DM1) were much more re- Based on in situ hybridization, neurons and cells of
the SVZ appear to be major sources of neuregulins insponsive to bFGF than to PDGF. The proliferative effects
of GGF are distinct from those of PDGF and bFGF in the developing and adult CNS (Corfas et al., 1995; Orr-
Urtreger et al., 1993; Vartanian et al., 1994). In addition,that it is equally effective on newly differentiated O41
cells and more mature O41 cells. Indeed, GGF was astrocytes also synthesize these proteins (Pinkas-Kra-
marski et al., 1994). While the identity of the cells ex-even mitogenic for oligodendrocytes.The notion that the
oligodendrocyte lineage is under the control of different pressing GGF in the SVZ has not yet been established,
this region is primarily comprised of glial progenitors inmitogens is also in general agreement with the temporal
pattern of expression of these growth factors in vivo. the early postnatal period (Levison and Goldman, 1993).
These findings suggest that both neurons and glia mayBoth PDGF (Yeh et al., 1991) and the neuregulins (Corfas
et al., 1995; Meyer and Birchmeier, 1994; Orr-Urtreger be physiologic sources of neuregulins during devel-
opment.et al., 1993) are expressed very early during CNS devel-
opment. The neuregulins, in particular, are expressed
well before the oligodendrocyte progenitors are thought
GGF Inhibits Lineage Commitment andto arise at approximately E16 in the rat forebrain (Levine
Oligodendrocyte and Astrocyte Differentiationand Goldman, 1988) and they persist, at lower levels,
Although axons are required for oligodendrocyte differ-into adulthood. By contrast, bFGF mRNA expression in
entiation and myelination, tissue culture studies suggestthe brain is first detectable postnatally and increases
that initially they promote proliferation and delay mye-into adulthood (Riva and Mocchetti, 1991). Taken to-
lination of oligodendrocyte progenitors (Dutly andgether, these results suggest that GGF and PDGF are
Schwab, 1991; Levine, 1989; Shaw et al., 1996; Zajiceklikely to regulate early progenitors, including O-2As and
and Compston, 1994). This inhibition of differentiationearly pro-oligodendrocytes, whereas GGF and bFGF
results from axolemma-associated factors (Zajicek andmay function at later times on more differentiated pro-
Compston, 1994). After this initial delay, and once anoligodendrocytes and oligodendrocytes. Whether GGF
appropriate cohort of oligodendrocytes is generated, acooperates with these other growth factors to regulate
later phase of differentiation ensues (Barres and Raff,the mitogenic response is an important question for
1994; Shaw et al., 1996; Wood and Bunge, 1991). Infuture investigation.
agreement with these initial effects of the axon, GGFNeurons are an important source of oligodendroglial
promotes proliferation and significantly inhibits differen-mitogens (Barres and Raff, 1994), releasing soluble fac-
tiation of oligodendrocyte progenitors beyond the O41/tors including PDGF (Dutly and Schwab, 1991; Zajicek
O12 stage. These effects of GGF resemble those ofand Compston, 1994) and bFGF (Hardy and Reynolds,
bFGF, which, as noted above, arrests cells in the O41/1993b; Logan and Logan, 1986) and stimulating prolifer-
O12 stage of differentiation (McKinnon et al., 1990).ation via contact-dependent factors (Chen and DeVries,
Similar effects of mitogens on Schwann cell myelination1989; Wood and Bunge, 1986). Central neurons (Gard
and Pfeiffer, 1990; Hardy and Reynolds, 1993b; Levine, (Einheber et al., 1995; Gue´nard et al., 1995; Morgan et al.,
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1994), including GGF (Cheng and Mudge, 1996; J. L. S., here, we investigated whether the effects of GGF were
isoform specific. We analyzed the mitogenic effects ofunpublished data) have also been observed. These re-
sults indicate that high level expression of neuronal mi- heregulin b1, the human homolog of ARIA, and found it
to be a potent mitogen, comparable in its efficacy withtogens can promote proliferation and arrest myelination
in both the CNS and PNS. GGF. In addition, treatment with heregulin b1 also ap-
pears to result in a similar loss of MBP1 cells in theThe ability of GGF to inhibit oligodendrocyte differenti-
ationraises the questionof howoligodendrocytes differ- treated cultures, although this effect has not been quan-
titated. These results indicate that the effects of GGFentiate and myelinate axons, which are likely to express
neuregulins at their cell surface. One possibility is that are not isoform specific, consistent with previous re-
ports that the epidermal growth factor domain is suffi-during CNS development, expression of neuregulin
(Chen et al., 1994) or its receptors (Jin et al., 1993; Kokai cient to mediate the mitogenic effects of the neuregulins
(Dong et al., 1995; Holmes et al., 1992; Morrissey et al.,et al., 1987) (or both) are down-regulated. In addition,
factors releasedby astroglia have beenreported to over- 1995). Potentially, methodologic differences between
these studies may contribute to the different effectscome the inhibition of differentiation of O-2A cells ob-
served with PDGF or bFGF (Dutly and Schwab, 1991; observed. First, Vartanian et al. also used supernatants
from transfected COS cells as their source of ARIA, andMayer et al., 1993) and could similarly modulate these
effects of GGF in vivo. therefore the concentration and purity of the material
added to the oligodendrocyte progenitors is unknown.The effects of GGF on type-2 astrocytes are complex.
Similar to its effects in the oligodendrocyte lineage, it Their studies were also done under serum-free condi-
tions, which we have found significantly reduced theinhibits the differentiation of O-2A cells into type-2 astro-
cytes. However, it also promotes a dramatic change in mitogenic effect of GGF and accentuated its trophic
effects. Finally, the cells used in our studies were ex-the morphology of type-2 astrocytes that have already
formed, resulting in the production of a few highly elon- panded with B104 conditioned media, which might en-
hance their responsiveness by up-regulating oligoden-gate processes (see Figure 1 and Figure 6). In addition,
GGF has a modest, but significant, mitogenic effect on droglial neuregulin receptors akin to the increase in
PDGF receptors observed with bFGF treatment (McKin-these cells. Some of these findings are similar to the
effects of a neuregulin isoform, NDF, on type-1 astro- non et al., 1990).
cytes (Pinkas-Kramarski et al., 1994). These investiga-
tors found that NDF had only a modest effect on
A General Role for GGF in Regulatingastrocyte proliferation, but promoted the formation of
Myelinating Glial Cell Numbersmore extensive processes. In addition, NDF promoted
The effects of GGF on the proliferation, survival, andastrocyte survival under serum-free conditions and in-
maturation of oligodendrocyte progenitors are strikinglycreased their maturation as evidenced by up-regulation
similar to its effects on cells of the Schwann cell lineage.of GFAP expression, effects of GGFon type-2 astrocytes
GGF has long been known to be a potent Schwannwe have not analyzed.
cell mitogen and has recently been implicated in theWe have further demonstrated that GGF inhibits the
contact-dependent stimulation of Schwann cell prolifer-ability of O-2A cells to commit to either the oligodendro-
ation by neurons (Morrissey et al., 1995). In otherstudies,cyte or astrocyte lineage. In the forebrain, O-2A cells
GGF has been found to inhibit the expression of myelin-arise primarily from the SVZ and, as noted, this is a
specific proteins by Schwann cells (Cheng and Mudge,region of high level expression of GGF-related proteins.
1996) and their ability to myelinate axons (M. J. Han-These findings raise the possibility that high level ex-
nocks, J. L. S., unpublished data). There also appearspression of GGF in this region may contribute to the
to be a transition in the expression of neuregulin recep-high rate of proliferation and the multipotential nature
tors in the Schwann cell lineage; progenitors, but notcharacteristic of cells in this region via an autocrine or
mature Schwann cells, expresserbB4 (Dong et al., 1995;paracrine mechanism. Although cells in the postnatal
Levi et al., 1995). This transition in receptor expressionSVZ are multipotential with respect to the glial lineage,
resembles that of the O-2A cells as they differentiategiving rise to either astrocytes or oligodendrocytes, they
into oligodendrocytes (see Figure 8). These changesonly rarely give rise to neurons (Levison and Goldman,
in the repertoire of receptor heterodimers expressed1993). Whether GGF commits these cells to the glial
during the glial lineage, in turn, could be an importantlineage as it does for cells of the neural crest origin
determinant of the cellular response, regulating receptor(Shah et al., 1994) is not yet known.
affinity and determining which intracellular signaling
pathways are activated (Carraway and Burden, 1995;
Riese et al., 1995).The Effects of GGF Are Not Isoform Specific
These findings contrast with a previous study (Vartanian Of particular note, Schwann cells (Jessen et al., 1994)
and oligodendrocytes (Barres et al., 1992) are overpro-et al., 1994), which reported that treatment of oligoden-
drocyte progenitors with ARIA, a related neuregulin iso- duced during development and undergo apoptosis ow-
ing to limiting amounts of nerve-derived survival factors.form, results in increased numbers of O11 cells from a
progenitor population. In that study, treatment with ARIA In vitro, neurons promotethe survival of oligodendrocyte
progenitors by a mechanism involving neuronal mem-did not increase the proliferation or survival of oligo-
dendrocyte progenitors, and it was therefore suggested brane–associated factors (reviewed by Barres and Raff,
1994). Recent studies have demonstrated that the neu-that ARIA promotes oligodendrocyte differentiation. As
these findings are in sharp contrast with those reported regulins promote the survival of perinatal Schwann cells
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were diluted in 0.1% bovine serum albumin (BSA)/PBS as follows:(Trachtenberg and Thompson, 1996) and their precur-
A2B5 monoclonal, 1:100; culture supernatants of the O4 monoclonalsors (Dong et al., 1995). The trophic effects of GGF on
and the O1 monoclonals were used at 1:10 and 1:1, respectivelyoligodendrocyte progenitors we have described here
(cell lines provided by S. Pfeiffer, University of Connecticut); OX42,
suggest that GGF could have a similar effect on the 1:100 (Harlan Bioproducts for Science); anti-GFAP, 1:500 (gift of A.
survival of these cells during CNS development. By pro- Bignami); anti-MBP 1:500 (gift of D. Colman). Staining with the O4
and O1 antibodies was performed on live and fixed cells as a controlmoting the survival and proliferation of both immature
for specificity, with comparable results. Fluorescein- or rhodamine-oligodendrocytes and Schwann cells, GGF may there-
conjugated secondary antibodies (Chemicon, Temecula, CA) werefore have a crucial role during development in adjusting
diluted 1:100 in 0.1% BSA/PBS. Cells stained with anti-GFAP orthe final number of myelinating glial cells to the number
anti-MBP were permeabilized in 0.1% Triton X-100 for 10 min and
of available axons. blocked for 30 min in 0.1% BSA/PBS before incubating with second-
In summary, we have demonstrated that GGF, a neu- ary antibodies.
regulin isoform, has potent effects on the proliferation,
differentiation, and survival of oligodendrocyte progeni-
Proliferation Assays
tors. These results strongly implicate GGF in the neu- To determine the percentage of cells synthesizing DNA, cultures
ronal regulation of oligodendrocyte development. Im- were incubated for 4 hr in the presence of 10 mM BrDU (Sigma).
Cultures were then washed in PBS, fixed in 4% paraformaldehydeportant questions remain regarding the significance of
for 15 min, permeabilized with 0.1% Triton X-100 in PBS, and stainedthe different neuregulin isoforms, their potential synergy
with the fluorescein-conjugated anti-BrDU diluted 1:10 in 0.1% BSA/with other oligodendroglial mitogens, how their activity
PBS for 1 hr following the instructions of the manufacturer (Boeh-is modulated during development, and whether they
ringer Mannheim). Slides were mounted in Citifluor (Citifluor Ltd.,
play a role in the response of the oligodendrocytes to London, U. K.) containing 1 mg/ml Hoechst nuclear dye. The labeling
injury, including remyelination. Analysis incoculture sys- index, corresponding to the ratio of BrDU1 cells to total cells, was
determined from photomicrographs of individual fields of BrDU-tems together with genetic strategies should further
labeled and Hoechst-stained nuclei. To determine the labeling indexclarify the precise physiologic role of the neuregulins in
at specific stages of differentiation, BrDU staining was combinedaxon–oligodendrocyte signaling.
with immunofluorescence analysis of O4 and O1 expression. Fixed
cells were stained with the appropriate antibody, washed, refixed,
Experimental Procedures and then permeablilized and processed for BrDU staining. A rhoda-
mine-labeled Mu chain–specific secondary antibody (Chemicon)
Cell Culture was included with the fluorescein anti-BrDU antibody.
Primary mixed glial cell cultures, generated from 2-day-old rat fore- Purified growth factors used in proliferation assays included
brains were maintained in DMEM with 10% FBS for 7–10 days, after PDGF AA (Sigma), bFGF (a gift of D. Rifkin, New York University
which O-2A progenitors and microglia were separated from type-1 Medical Center), or rhGGF2 (Cambridge Neuroscience, Cambridge,
astrocytesby shaking the cultures 250 RPM for 12 hr at 378C(McCar- MA). Heregulin b1 was generated in Sf9 cells infected with a recom-
thy and DeVellis, 1980). The detached O-2A cells and microglia were binant baculovirus expression vector as previously described (Jo
replated onto uncoated tissue culture dishes and left to adhere for et al., 1995); controls consisted of conditioned media from Sf9 cells
3 hr. This allowed the microglia to become firmly attached, whereas infected with the control vector (both gifts of S. Burden, NYU Medical
the O-2A progenitors were loosely attached. The O-2A cells were Center). The Sf9 conditioned media was used at a dilution of 1:100,
detached by gentle flushing, replated onto poly-L-lysine-coated a concentration optimized by receptor phosphorylation studies.
dishes, and allowed to adhere overnight. The O-2A cultures were Cortical neuron conditioned media was prepared as previously de-
treated with 5 mM leucine methylester (Sigma Chemical Company, scribed (Hardy and Reynolds, 1993b). Neutralizing antibodies to
St. Louis, MO) for 15 min at room temperature to kill any remaining bFGF (a gift of D. Rifkin, NYU Medical Center), PDGF (R & D) and
microglia, and then washed three times with DMEM. O-2A cells were a rabbit polyclonal antibodyraised against rhGGF2 (Cambridge Neu-
grown in N2 media containing 10 ng/ml biotin, 30 nM T3, and 0.5% roscience) were used. In experiments in which these antibodies were
FBS (DM1) as described (McKinnon et al., 1990) and expanded by used to characterize mitogenic activities, purified growth factors or
supplementing this media with either bFGF (5 ng/ml) and PDGF conditioned media were preincubated with the appropriate antibody
(10 ng/ml) or, routinely, with 30% B104 conditioned media. (B104 for 30 min at 378C prior to addition to the cells. In control studies,
conditioned media was collected every 2 days from confluent cul- the anti-PDGF antibody, alone or together with an anti-bFGF anti-
tures of this neuroblastoma line that were maintained in DM1.) Cells body, had no effect on the mitogenic activity of GGF whereas these
expanded in this manner remained undifferentiated andhighly prolif- antibodies completely inhibited the mitogenic activity of bFGF and
erative, as previously described (Bo¨gler et al., 1990; Bottenstein and PDGF, respectively (data not shown).
Hunter,1990). After six passages, aliquots of 106 cells were prepared
and frozen in liquid nitrogen. Individual aliquots were used for up
to 3 months with no change in their bipolar morphology or their Survival Assays
pattern of antigen expression. To generate cells of the oligodendro- To assess the effect of GGF on cell survival, cells growing in B104
cyte lineage, this media was removed and replaced with DM1 for conditioned media were changed to DM1 media for 3 days. They
1–3 days. To generate type-2 astrocytes, cells were switched to were then switched to either N2 media or DMEM, with or without
DMEM supplemented with 20% FBS for 3 or more days. GGF, for 12 or 24 hr and stained with the Live/Dead staining kit
(Molecular Probes, Inc., Eugene, OR) for 15 minfollowing the instruc-
tions of the manufacturer. This method relies on the differentialImmunofluorescence Analysis
Purity of the cultures was established by immunofluorescence anal- permeability of live and dead cells to a pair of fluorescent nuclear
stains (when viewed with epifluorescence microscopy, the nuclei ofysis using a series of antibodies directed against GFAP as a marker
for astrocytes; OX42 monoclonal, a marker for microglia (Harlan live cells appear green whereas those of dead cells appear red).
Because of fading of the green fluorescent dye, in later experimentsBioproducts for Science, Indianapolis, IN); anti-A2B5 monoclonal
(Boehringer Mannheim, Indianapolis, IN), a marker for O-2A progeni- we used the Hoechst dye (Sigma) at 1 mg/ml after fixation as a
substitute with similar results and less fading. The number of redtors; O4 and O1, which recognize early and mature oligodendro-
cytes, respectively (Sommer and Schachner, 1980). Cells used for and Hoechst dye–labeled nuclei in each field were then counted
from the Ektachrome slides projected on a slide viewer; we countedimmunofluorescence analysis were grown on poly-L-lysine-coated
Lab-Tek eight chamber slides (Nunc). Slides were washed in phos- $1,000 cells per condition. In some experiments, we also used
morphologic criteria, i.e., monitoring pyknotic cells under phasephate-buffered saline (PBS), fixed in 4% paraformaldehyde for 15
min, and processed for immunofluorescence. Primary antibodies microscopy, and the MTT assay (Sigma).
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Analysis of GGF Receptors Chen, M.S., Bermingham-McDonogh, O., Danehy, F., Jr., Nolan, C.,
Scherer, S.S., Lucas, J., Gwynne, D., and Marchionni, M.A. (1994).To analyze the expression of GGF receptors, cells at different stages
of the oligodendrocyte lineage were treated with rhGGF2 at 200 ng/ Expression of multiple neuregulin transcripts in postnatal rat brains.
J. Comp. Neurol. 349, 389–400.ml in defined media for 2.5 min at 378C. Cells were quickly rinsed
twice with ice cold PBS and lysed in cold lysis buffer containing Chen, S.-J., and DeVries, G.H. (1989). Mitogenic effect of axolemma-
1% NP 40, 50 mM Tris HCl (pH 7.4), 150 mM NaCl, 10% glycerol, enriched fraction on cultured oligodendrocytes. J. Neurochem. 52,
5 mM EGTA, 1 mM Na orthovanadate, 10 mM Na molybdate, 8.8 325–327.
g/L Na pyrophosphate, 4 g/L NaFl, 1 mM PMSF, 10 mg/ml aprotinin,
Cheng, L., and Mudge, A.W. (1996). Cultured Schwann cells consti-and 20 mM leupeptin. Lysates were centrifuged at 12,000 3 g at
tutively express the myelin protein P0. Neuron 16, 309–319.48C for 20 min, and supernatants were reserved for analysis. We
Collarini, E.J., Kuhn, R., Marshall, C.J., Monuki, E.S., Lemke, G., andfractionated 15 mg of protein lysates by SDS–PAGE, electroblotted
Richardson, W.D. (1992). Down-regulation of the POU transcriptiononto nitrocellulose, and probed with antibodies to either erbB2,
factor is an early event in oligodendrocyte differentiation in vitro.erbB3, and erbB4 (Santa Cruz Biotechnology, Santa Cruz, CA) or
Development 116, 193–200.with the anti-phosphotyrosine antibody RC 20 (Transduction Labo-
ratories, Lexington, KY). Reacting protein bands were subsequently Corfas, G., Rosen, K.M., Aratake, H., Krauss, R., and Fischbach,
visualized by chemiluminescence following the instructions of the G.D. (1995). Differential expression of ARIA isoforms in the rat brain.
manufacturer (Amersham, Arlington Heights, IL). To analyze which Neuron 14, 103–115.
receptor subunits were phosphorylated after GGF treatment, cells David, S., Miller, R.H., Patel, R., and Raff, M.C. (1984). Effects of
were lysed as above and aliquots of 150 mg were incubated with neonatal transection on glial cell development in the rat optic nerve:
the biotinylated RC 20 anti-phosphotyrosine antibody overnight at evidence that the oligodendrocyte-type-2 astrocyte cell lineage de-
48C. Immunoprecipitates were collected with streptavidin agarose pends on axons for its survival. J. Neurocytol. 13, 961–974.
beads (Pierce Chemical Company, Rockford, IL) and released by
Dong, Z., Brennan, A., Liu, N., Yarden, Y., Lefkowitz, G., Mirsky, R.,boiling in SDS sample buffer. Samples were fractionated by SDS–
and Jessen, K.R. (1995). Neu differentiation factor is a neuron-gliaPAGE, electroblotted, and probed with the erbB-specific antibodies
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